Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention–induced myocardial injury

BACKGROUND: Trimetazidine (TMZ) is a metabolic modulator that shifts substrate utilization from fatty acid to carbohydrates, thereby, increasing myocardial glucose oxidation and improving myocardial ischemia. We evaluated whether TMZ is effective in reducing myocardial injury after percutaneous coro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Indian Heart J
Autori principali: Kazmi, Danish H., Kapoor, Aditya, Sinha, Archana, Ambesh, Paurush, Kashyap, Shiridhar, Khanna, Roopali, Kumar, Sudeep, Garg, Naveen, Tewari, Satyendra, Goel, Pravin K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2018
Soggetti:
Interventional Cardiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309873/
https://ncbi.nlm.nih.gov/pubmed/30595291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2018.10.415
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi